127 related articles for article (PubMed ID: 29473206)
1. Association of Mac-2-binding protein glycosylation isomer level with nutritional status in chronic liver disease.
Eso Y; Takai A; Taura K; Takahashi K; Ueda Y; Marusawa H; Seno H
J Gastroenterol Hepatol; 2018 Feb; ():. PubMed ID: 29473206
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy of Mac-2-binding protein glycosylation isomer as a biomarker for albumin-bilirubin grade and the Controlling Nutritional Status score in chronic liver disease: investigation of cut-off values by the type of chronic liver disease.
Ishikawa T; Kodama E; Kobayashi T; Azumi M; Nozawa Y; Iwanaga A; Sano T; Honma T
Ann Palliat Med; 2022 Aug; 11(8):2658-2667. PubMed ID: 35815452
[TBL] [Abstract][Full Text] [Related]
3. Serum Mac-2 binding protein glycosylation isomer level predicts hepatocellular carcinoma development in E-negative chronic hepatitis B patients.
Mak LY; To WP; Wong DK; Fung J; Liu F; Seto WK; Lai CL; Yuen MF
World J Gastroenterol; 2019 Mar; 25(11):1398-1408. PubMed ID: 30918432
[TBL] [Abstract][Full Text] [Related]
4. Clinical usefulness of Mac-2 binding protein glycosylation isomer for diagnosing liver cirrhosis and significant fibrosis in patients with chronic liver disease: A retrospective single-center study.
Park HJ; Seo KI; Lee SU; Han BH; Yun BC; Park ET; Lee J; Hwang H; Yoon M
Medicine (Baltimore); 2022 Oct; 101(40):e30489. PubMed ID: 36221351
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Performance of Mac-2-Binding Protein Glycosylation Isomer (M2BPGi), compared to Transient Elastography to Assess Liver Stiffness in Treatment Naïve Chronic Hepatitis C Patients.
Sulaiman AS; Hasan I; Lesmana CRA; Kurniawan J; Jasirwan COM; Nababan S; Kalista KF; Hanifa RS; Rachmani D; Gani RA
Acta Med Indones; 2022 Oct; 54(4):567-573. PubMed ID: 36624717
[TBL] [Abstract][Full Text] [Related]
6. Role of Serum M2BPGi Levels in Predicting Persistence of Advanced Fibrosis in Chronic Hepatitis B Virus Infection.
Mak LY; Wong DK; Cheung KS; Hui RW; Liu F; Fung J; Seto WK; Yuen MF
Dig Dis Sci; 2022 Nov; 67(11):5127-5136. PubMed ID: 35258755
[TBL] [Abstract][Full Text] [Related]
7. Correlation of serum Mac-2-binding protein glycosylation isomer (M2BPGi) and liver stiffness in chronic hepatitis B infection.
Mak LY; Wong DK; Seto WK; Ning Q; Cheung KS; Fung J; Lai CL; Yuen MF
Hepatol Int; 2019 Mar; 13(2):148-156. PubMed ID: 30671807
[TBL] [Abstract][Full Text] [Related]
8. Early detection of liver fibrosis with serum Mac-2 binding protein glycosylation-modified isomer (M2BPGi) during follow-up intestinal failure patients without intestinal failure-associated liver disease (IFALD).
Ueno T; Takase K; Deguchi K; Masahata K; Nomura M; Watanabe M; Kamiyama M; Tazuke Y; Bessho K; Okuyama H
Pediatr Surg Int; 2022 Dec; 38(12):1807-1813. PubMed ID: 36125546
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of Mac-2 binding protein glycosylation isomer (M2BPGi) in screening liver fibrosis in health checkups.
Nah EH; Cho S; Kim S; Kim HS; Cho HI
J Clin Lab Anal; 2020 Aug; 34(8):e23316. PubMed ID: 32227396
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of M2BPGi, compared with Fibro Scan®, in analysis of liver fibrosis in patients with hepatitis C.
Xu H; Kong W; Liu L; Chi X; Wang X; Wu R; Gao X; Wang H; Qu L; Qi Y; Pan Y; Niu J
BMC Gastroenterol; 2017 May; 17(1):62. PubMed ID: 28486931
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic performance of Mac-2-binding protein glycosylation isomer (M2BPGi) as a liver fibrosis marker in chronic hepatitis C patients with chronic kidney disease on hemodialysis.
Sulaiman AS; Hasan I; Hustrini NM; Lydia A; Hanifa RS; Gani RA
Clin Exp Nephrol; 2023 Jun; 27(6):557-564. PubMed ID: 36995542
[TBL] [Abstract][Full Text] [Related]
12. Evaluating M2BPGi as a Marker for Liver Fibrosis in Patients with Chronic Hepatitis B.
Bui HH; Nguyen ST; Phan ST; Nguyen KM; Nguyen CD
Dig Dis Sci; 2023 Dec; 68(12):4407-4417. PubMed ID: 37861877
[TBL] [Abstract][Full Text] [Related]
13. Serum angiopoietin-2 levels predict regression of Mac-2 binding protein glycosylation isomer-based liver fibrosis after hepatitis C virus eradication by direct-acting antiviral agents.
Suzuki T; Matsuura K; Nagura Y; Ogawa S; Fujiwara K; Nojiri S; Watanabe T; Kataoka H; Tanaka Y
Hepatol Res; 2022 Nov; 52(11):919-927. PubMed ID: 35938598
[TBL] [Abstract][Full Text] [Related]
14. Serum Mac-2 binding protein glycosylation isomer predicts grade F4 liver fibrosis in patients with biliary atresia.
Yamada N; Sanada Y; Tashiro M; Hirata Y; Okada N; Ihara Y; Urahashi T; Mizuta K
J Gastroenterol; 2017 Feb; 52(2):245-252. PubMed ID: 27349650
[TBL] [Abstract][Full Text] [Related]
15. Serum Mac-2 binding protein glycosylation isomer predicts the activation of hepatic stellate cells after liver transplantation.
Yamada N; Katano T; Hirata Y; Okada N; Sanada Y; Ihara Y; Urahashi T; Ushijima K; Karasawa T; Takahashi M; Mizuta K
J Gastroenterol Hepatol; 2019 Feb; 34(2):418-424. PubMed ID: 30101431
[TBL] [Abstract][Full Text] [Related]
16. Serum Mac-2-Binding Protein Glycosylation Isomer at Virological Remission Predicts Hepatocellular Carcinoma and Death in Chronic Hepatitis B-Related Cirrhosis.
Su TH; Peng CY; Tseng TC; Yang HC; Liu CJ; Liu CH; Chen PJ; Chen DS; Kao JH
J Infect Dis; 2020 Feb; 221(4):589-597. PubMed ID: 31574141
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of serum Mac-2 binding protein glycosylation isomer in patients undergoing hepatectomy: A case controlled study.
Hiyoshi M; Yano K; Nanashima A; Ikenoue M; Imamura N; Fujii Y; Hamada T; Nishida T
Ann Med Surg (Lond); 2019 Dec; 48():17-22. PubMed ID: 31692665
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Efficacy of Serum Mac-2 Binding Protein Glycosylation Isomer and Other Markers for Liver Fibrosis in Non-Alcoholic Fatty Liver Diseases.
Jang SY; Tak WY; Park SY; Kweon YO; Lee YR; Kim G; Hur K; Han MH; Lee WK
Ann Lab Med; 2021 May; 41(3):302-309. PubMed ID: 33303715
[TBL] [Abstract][Full Text] [Related]
19. Liver fibrosis assessments using FibroScan, virtual-touch tissue quantification, the FIB-4 index, and mac-2 binding protein glycosylation isomer levels compared with pathological findings of liver resection specimens in patients with hepatitis C infection.
Ueda N; Kawaoka T; Imamura M; Aikata H; Nakahara T; Murakami E; Tsuge M; Hiramatsu A; Hayes CN; Yokozaki M; Chayama K
BMC Gastroenterol; 2020 Sep; 20(1):314. PubMed ID: 32977741
[TBL] [Abstract][Full Text] [Related]
20. Serum Mac-2-binding protein glycosylation isomer and risk of hepatocellular carcinoma in entecavir-treated chronic hepatitis B patients.
Mak LY; Ko M; To E; Wong DK; Ma JH; Hui TL; Seto WK; Fung J; Lai CL; Yuen MF
J Gastroenterol Hepatol; 2019 Oct; 34(10):1817-1823. PubMed ID: 30786068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
